Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents

by Geert van Tetering, Mitchell Evers, Chilam Chan, Marjolein Stip, Jeanette Leusen
Published 2020-12-01

Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?

by Chilam Chan, Marta Lustig, Niklas Baumann, Thomas Valerius, Geert van Tetering, Jeanette H. W. Leusen
Published 2022-07-01

Corrigendum: Targeting myeloid checkpoint molecules in combination with antibody therapy: A novel anti-cancer strategy with IgA antibodies?

by Chilam Chan, Marta Lustig, Niklas Baumann, Thomas Valerius, Geert van Tetering, Jeanette H. W. Leusen
Published 2022-09-01

Enhancing IgA-mediated neutrophil cytotoxicity against neuroblastoma by CD47 blockade

by Judith Wienke, Maaike Nederend, Jeanette Leusen, Marjolein Stip, Marco Jansen, Chilam Chan, Femke van den Ham, Geert van Tetering, Elsemieke Passchier
Published 2024-05-01

Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9

by Chilam Chan, Marta Lustig, J. H. Marco Jansen, Laura Garcia Villagrasa, Leon Raymakers, Lois A. Daamen, Thomas Valerius, Geert van Tetering, Jeanette H. W. Leusen
Published 2023-06-01

IgA antibody immunotherapy targeting GD2 is effective in preclinical neuroblastoma models

by Miranda P Dierselhuis, Maaike Nederend, Jeanette H W Leusen, Mitchell Evers, Marco Jansen, Chilam Chan, Thomas Valerius, Friederike Meyer-Wentrup, Annelisa M Cornel, Marjolein C Stip, Karli R Reiding, Mirjam J Damen, Albert J R Heck, Sofia Koustoulidou, Ruud Ramakers, Gerard C Krijger, Remmert de Roos, Edouard Souteyrand, Mark de Boer, Geert van Tetering
Published 2023-07-01